Literature DB >> 15683091

Sickle cell disease; a general overview.

J B Schnog1, A J Duits, F A J Muskiet, H ten Cate, R A Rojer, D P M Brandjes.   

Abstract

Sickle cell disease (SCD) is a heterogeneous disorder, with clinical manifestations including chronic haemolysis, an increased susceptibility to infections and vaso-occlusive complications often requiring medical care. Patients with SCD can develop specific and sometimes life-threatening complications, as well as extensive organ damage reducing both their quality of life and their life expectancy. Proven effective treatment options for sickle cell patients are limited to hydroxyurea, blood transfusions and bone marrow transplantation. With the increasing prevalence of SCD in the Netherlands, a fundamental understanding of its pathophysiology and clinical syndromes is of importance for local medical practitioners.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15683091

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  36 in total

1.  Free heme and the polymerization of sickle cell hemoglobin.

Authors:  Veselina V Uzunova; Weichun Pan; Oleg Galkin; Peter G Vekilov
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

2.  An unusual case of a spurious, transfusion-acquired haemoglobin S.

Authors:  Giuseppe Lippi; Mariella Mercadanti; Caleffi Alberta; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

3.  Current therapy of sickle cell disease.

Authors:  Zakari Y Aliyu; Ashaunta R Tumblin; Gregory J Kato
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

4.  The "fish-vertebra" sign.

Authors:  P G Ntagiopoulos; D-A Moutzouris; S Manetas
Journal:  Emerg Med J       Date:  2007-09       Impact factor: 2.740

5.  Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease.

Authors:  Mutlu Kasar; Can Boğa; Mahmut Yeral; Suheyl Asma; Ilknur Kozanoglu; Hakan Ozdogu
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

6.  The "fish-vertebra" sign.

Authors:  Panagiotis G Ntagiopoulos; Dimitrios Anestis Moutzouris; S Manetas
Journal:  BMJ Case Rep       Date:  2009-02-02

7.  Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy.

Authors:  Elisa Ballardini; Anna Tarocco; Maria Marsella; Roberto Bernardoni; Gianni Carandina; Claudia Melandri; Giovanni Guerra; Alfredo Patella; Miranda Zucchelli; Alessandra Ferlini; Stefania Bigoni; Anna Ravani; Giampaolo Garani; Caterina Borgna-Pignatti
Journal:  Blood Transfus       Date:  2012-09-12       Impact factor: 3.443

Review 8.  Novel insights in the management of sickle cell disease in childhood.

Authors:  Lorenzo Iughetti; Elena Bigi; Donatella Venturelli
Journal:  World J Clin Pediatr       Date:  2016-02-08

9.  Coping and coping assistance among children with sickle cell disease and their parents.

Authors:  Aimee K Hildenbrand; Lamia P Barakat; Melissa A Alderfer; Meghan L Marsac
Journal:  J Pediatr Hematol Oncol       Date:  2015-01       Impact factor: 1.289

10.  Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia.

Authors:  Danilo Grunig Humberto Silva; Edis Belini Junior; Gisele Cristine de Souza Carrocini; Lidiane de Souza Torres; Octávio Ricci Júnior; Clarisse Lopes de Castro Lobo; Claudia Regina Bonini-Domingos; Eduardo Alves de Almeida
Journal:  BMC Med Genet       Date:  2013-10-09       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.